Skip to main content
In stock|Immunotherapy (Cytokine)

Denileukin Diftitox

Oncology TypeHematologic (Lymphoma)
Drug Class / MechanismIL-2 / Diphtheria Toxin Fusion Protein, anti-CD25
No Image
Description

Denileukin Diftitox is classified as an IL-2 / Diphtheria Toxin Fusion Protein, anti-CD25, sourced for use within our Immunotherapy (Cytokine) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryImmunotherapy (Cytokine)
Oncology TypeHematologic (Lymphoma)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3